July 9, 2024 01:26 PM EDT
Pharma
Law

In­tel­lia to re­spond to law­suit over in vi­vo ther­a­py patents

Katherine Lewin

News Reporter

In­tel­lia Ther­a­peu­tics said it will re­spond to a law­suit filed Mon­day in a Delaware fed­er­al court al­leg­ing it in­fringed on sev­er­al of BlueAl­lele’s patents cov­er­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

Idor­sia eyes lay­offs, tees up Tryvio li­cens­ing deal to ex­tend cash run­way

Ad­vanz Phar­ma faces re­vo­ca­tion of Eu­ro­pean au­tho­riza­tion for liv­er dis­ease drug Ocali­va

Out­look's shares crash as wet AMD drug flunks Phase 3 test

A service from the Financial Times